Nagashima M - Search Results

1

Identification of a functional domain in a GADD45-mediated G2/M checkpoint.

Yang Q, Manicone A, Coursen JD, Linke SP, Nagashima M, Forgues M, Wang XW. Yang Q, et al. Among authors: nagashima m. J Biol Chem. 2000 Nov 24;275(47):36892-8. doi: 10.1074/jbc.M005319200. J Biol Chem. 2000. PMID: 10973963 Free article.

2

DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.

Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke SP, Pedeux R, Wang XW, Yokota J, Riabowol K, Harris CC. Nagashima M, et al. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9671-6. doi: 10.1073/pnas.161151798. Epub 2001 Jul 31. Proc Natl Acad Sci U S A. 2001. PMID: 11481424 Free PMC article.

3

COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis.

Zhou X, Wang XW, Xu L, Hagiwara K, Nagashima M, Wolkowicz R, Zurer I, Rotter V, Harris CC. Zhou X, et al. Among authors: nagashima m. Cancer Res. 1999 Feb 15;59(4):843-8. Cancer Res. 1999. PMID: 10029073

4

p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.

Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y, Appella E, Yokota J, Harris CC. Shiseki M, et al. Among authors: nagashima m. Cancer Res. 2003 May 15;63(10):2373-8. Cancer Res. 2003. PMID: 12750254

5

Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.

Vincent F, Nagashima M, Takenoshita S, Khan MA, Gemma A, Hagiwara K, Bennett WP. Vincent F, et al. Among authors: nagashima m. Oncogene. 1997 Jul 3;15(1):117-22. doi: 10.1038/sj.onc.1201166. Oncogene. 1997. PMID: 9233784

6

A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.

Nagashima M, Shiseki M, Pedeux RM, Okamura S, Kitahama-Shiseki M, Miura K, Yokota J, Harris CC. Nagashima M, et al. Oncogene. 2003 Jan 23;22(3):343-50. doi: 10.1038/sj.onc.1206115. Oncogene. 2003. PMID: 12545155

7

Mutational analysis of p73 and p53 in human cancer cell lines.

Yoshikawa H, Nagashima M, Khan MA, McMenamin MG, Hagiwara K, Harris CC. Yoshikawa H, et al. Among authors: nagashima m. Oncogene. 1999 Jun 3;18(22):3415-21. doi: 10.1038/sj.onc.1202677. Oncogene. 1999. PMID: 10362363

8

The genomic structure of the gene encoding the human transforming growth factor beta type II receptor (TGF-beta RII).

Takenoshita S, Hagiwara K, Nagashima M, Gemma A, Bennett WP, Harris CC. Takenoshita S, et al. Among authors: nagashima m. Genomics. 1996 Sep 1;36(2):341-4. doi: 10.1006/geno.1996.0471. Genomics. 1996. PMID: 8812462

9

Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E, Nagashima M, Takenoshita S, Yokota J, Harris CC. Kumamoto K, et al. Among authors: nagashima m. Cancer Res. 2008 May 1;68(9):3193-203. doi: 10.1158/0008-5472.CAN-07-2780. Cancer Res. 2008. PMID: 18451145 Free PMC article.

10

Targeted disruption of Ing2 results in defective spermatogenesis and development of soft-tissue sarcomas.

Saito M, Kumamoto K, Robles AI, Horikawa I, Furusato B, Okamura S, Goto A, Yamashita T, Nagashima M, Lee TL, Baxendale VJ, Rennert OM, Takenoshita S, Yokota J, Sesterhenn IA, Trivers GE, Hussain SP, Harris CC. Saito M, et al. Among authors: nagashima m. PLoS One. 2010 Nov 19;5(11):e15541. doi: 10.1371/journal.pone.0015541. PLoS One. 2010. PMID: 21124965 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

977 results

Search Page

Filters